Jove
Visualize
Contact Us

Related Experiment Videos

Reporting adverse events in randomized controlled trials.

Jim Nuovo1, Curtis Sather

  • 1Department of Family and Community Medicine, University of California, Davis, Sacramento, CA 95817, USA. james.nuovo@ucdmc.ucdavis.edu

Pharmacoepidemiology and Drug Safety
|September 26, 2006
PubMed
Summary

Reporting of adverse events in randomized controlled trials varies significantly. Authors and editors should improve consistency in detailing side effects to ensure patient safety and trial transparency.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploration of Mistreatment and Burnout Among Resident Physicians: a Cross-Specialty Observational Study.

Medical science educator·2021
Same author

The impact of a diabetes self-management education program provided through a telemedicine link to rural california health care clinics.

Health services insights·2014
Same author

Establishing electronic health record competency testing for first-year residents.

Journal of graduate medical education·2014
Same author

Gender differences in the selection of an action plan for patients with type 2 diabetes mellitus.

The patient·2012
Same author

Systematic review: Adverse effects of treatment in randomised controlled trials are variably and inconsistently reported.

Evidence-based medicine·2010
Same author

Using Geographic Information Systems (GIS) to assess outcome disparities in patients with type 2 diabetes and hyperlipidemia.

Journal of the American Board of Family Medicine : JABFM·2010
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Clinical Trials
  • Medical Research
  • Pharmacovigilance

Background:

  • Reporting of adverse events in randomized controlled trials (RCTs) is crucial for assessing drug safety.
  • Inconsistent reporting practices may obscure potential risks and patient safety concerns.

Purpose of the Study:

  • To analyze and describe the methods used for reporting adverse events in published RCTs.
  • To identify variations in how adverse events are presented across major medical journals.

Main Methods:

  • A manual review of 521 eligible RCTs published between January 2000 and June 2003 in five high-impact medical journals.
  • Data extraction focused on the mention and location of adverse event information (abstract, methods, results, discussion, tables, figures) and dedicated subheadings.

Related Experiment Videos

Main Results:

  • Adverse events were mentioned in abstracts (63%), methods (73%), results (89%), and tables (48%).
  • A separate subheading for adverse events in the results section was present in only 46% of articles.
  • Significant variation was observed in reporting practices across journals and within different sections of the articles.

Conclusions:

  • There is considerable heterogeneity in the reporting of adverse events in RCTs.
  • Authors and journal editors should strive for greater consistency and clarity in presenting adverse event data.
  • Standardized reporting of adverse events is essential for comprehensive safety evaluation and informed clinical decision-making.